Title: Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.
Journal: Investigational new drugs20121001
Title: Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia.
Journal: British journal of haematology20120901
Title: Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.
Journal: Leukemia20120701
Title: Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia.
Journal: Leukemia research20120401
Title: Elacytarabine--lipid vector technology overcoming drug resistance in acute myeloid leukemia.
Journal: Expert opinion on investigational drugs20111201
Title: A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
Journal: Cancer chemotherapy and pharmacology20111101
Title: Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity.
Journal: Current medicinal chemistry20110101
Title: The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues.
Journal: Nucleosides, nucleotides & nucleic acids20100601
Title: Induction of resistance to the lipophilic cytarabine prodrug elacytarabine (CP-4055) in CEM leukemic cells.
Journal: Nucleosides, nucleotides & nucleic acids20100601
Title: Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.
Journal: International journal of oncology20100101
Title: Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study.
Journal: Acta oncologica (Stockholm, Sweden)20090101
Title: CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines.
Journal: British journal of haematology20090101
Title: Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Journal: Leukemia & lymphoma20080401
Title: Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Journal: Biochemical pharmacology20040201
Title: DiNardo CD, et al. Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia. Future Oncol. 2013 Aug;9(8):1073-82.
